Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II-III triple negative breast cancer: a retrospective analysis.

Huibo WangNana ZhangQi SunZiqi ZhaoHui PangXiatian HuangRuifeng ZhangWenli KangMing Shan

Published in: Journal of cancer research and clinical oncology (2024)

In stage II-III triple TNBC patients, the NACT regimen combining taxanes and carboplatin yields higher rates of pCR and significant improvements in EFS and OS as compared to the regimen combining anthracyclines and taxanes.

Keyphrases

neoadjuvant chemotherapy
end stage renal disease
locally advanced
ejection fraction
phase ii study
lymph node
prognostic factors
peritoneal dialysis
squamous cell carcinoma
early stage
patient reported outcomes